期刊文献+

喉癌患者树突状细胞的体外培养和功能研究 被引量:2

Study on the culture and the function of dendritic cells of patients with laryngeal squamous cell carcinoma in vitro
暂未订购
导出
摘要 目的体外分离培养喉鳞状细胞癌患者外周血来源的树突状细胞(dendriticcell| OBJECTIVE To culture dendritic cells from the peripheral blood ofpatients with laryngeal squamous cell carcinoma. METHODS Peripheral blood was collected from patients under sterile conditions. The mononuclear cells were separated by centrifugation through a density gradient (Ficoll- Hypaque). The adhesion cells, collected from the mononuclear cells, were cultured with interleukin-4 (IL-4, 100ng),granulocyte/macrophage colony stimulating factor (GM-CSF, 100ng) and tumor necrosis factor a (TNF-α, 100ng) in RPMI 1640 medium for 7 days. The cell morphology was observed under electronic microscope, and the characteristic surface marker CD80 of the cells was analyzed by flow cytometry. MTT colorimetry was employed to assess the proliferation of the mixed lymphocytes. The mixed lymphocytes were stimulated by DC loaded with laryngeal carcinoma antigen. RESULTS A large quantity of cells characteristic of dendritic cell was obtained. Cytometry analysis showed that 33.76 % of mononuclear cells expressed the characteristic marker CD80. After being cultured for 7 days, the expression level of CD80 was significantly increased (69.15 %). Few DC with laryngeal carcinoma antigen could play a role in stimulating lymphocyte proliferation, and the proliferation effect was optimized when the ratio between DC and T cells was 1:5. CONCLUSION A large number of DCs with high purity and sufficient treatment dose can be cultured in vitro from the peripheral blood of patients with laryngeal carcinoma. This technique may play an important role in experimental studies for clinical applications.
出处 《中国耳鼻咽喉头颈外科》 北大核心 2006年第3期149-152,共4页 Chinese Archives of Otolaryngology-Head and Neck Surgery
基金 黑龙江攻关课题资助项目(GB01C124-04)
关键词 喉肿瘤 鳞状细胞 树突细胞 粒细胞集落刺激因子 肿瘤坏死因子 白细胞介素4 Laryngeal Neoplasms Carcinoma,Squamous Cell Dendritic cell Granulocyte ColonyStimulating Factor Tumor Necrosis Factor Interleukin-4
  • 相关文献

参考文献4

  • 1[1]Riccobon A,Ridolfi R,Galassi R,et al.Migration of dendritic cells to regional lymph nodes in a vaccination trial.Cancer Cell International,2004,4:15.
  • 2[2]Timmerman JM,Czerwinski DK,Davis TA,et al.Ldiotype pulsed dendritic cell vaccination for B cell lymphoma:clinical and immune responses in 35 patients.J Blood,2002,95:1517-1526.
  • 3[3]Poindexter NJ,Sahin A,Hunt KK,et al.Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer.Breast Cancer Res,2004,6:408-415.
  • 4[4]Hildenbrand B,Langenkamp A,Sauer B,et al.Dendritic cell based immunotherapy of hormone refractory prostate carcinoma (HRPCa)-a pilot trial.Cancer cell International,2004,4:39.

同被引文献25

  • 1Gao C,Pan J,Lu W,et al. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells[J]. Anticancer Drugs,2009,20(9):807-814.
  • 2Prince A,Aguirre-Ghizo J,Genden E,et al. Head and neck squamous cell carcinoma: new translational therapies[J]. Mt Sinai J Med,2010,77(6):684-699.
  • 3Banchereau J,Palucka AK. Dendritic cells as therapeutic vaccines against cancer[J]. Nat Rev Immunol,2005,5(4):296-306.
  • 4Decker WK,Xing D,Shpall EJ. Dendritic cell immunotherapy for the treatment of neoplastic disease[J]. Biol Blood Marrow Transplant,2006,12(2):113-125.
  • 5Evel-Kabler K,Chen SY. Dendritic cell-based tumor vaccines and antigen presentation attenuators[J]. Mol Ther,2006,13(5):850-858.
  • 6Ryo A,Tsurutani N,Ohba K,et al. SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag[J]. Proc Natl Acad Sci U S A,2008,105(1):294-299.
  • 7Oh J,Hur MW,Lee CE. SOCS1 protects protein tyrosine phosphatases by thioredoxin upregulation and attenuates Jaks to suppress ROS-mediated apoptosis[J]. Oncogene,2009,28(35):3145-3156.
  • 8Rolinski J,Hus I. Dendritic-cell tumor vaccines[J]. Transplant Proc,2010,42(8):3306-3308.
  • 9Eksioglu EA,Eisen S,Reddy V. Dendritic cells as therapeutic agents against cancer[J]. Front Biosci,2010,15:321-347.
  • 10Hanada T,Yoshida H,Kato S,et al. Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity[J]. Immunity,2003,19(3):437-450.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部